Search Filters

Search Results

Found 1 results

510(k) Data Aggregation

    K Number
    K141916
    Date Cleared
    2014-08-07

    (23 days)

    Product Code
    Regulation Number
    874.4420
    Reference & Predicate Devices
    Predicate For
    AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
    Intended Use

    To locate, illuminate within, and transilluminate across nasal and sinus structures in patients aged 18 and over.

    Device Description

    The PathAssist LED Light Fiber is a flexible instrument that emits light from the distal end. The LED Light Fiber is provided sterile and is for single use only. The device consists of a flexible illumination fiber, a protective sheath and an integrated battery powered LED light source. When the LED Light Fiber is activated the fiber will emit red light from the distal tip for over 60 minutes. It has a fiber nominal working length of 27.6cm with an outer diameter of 0.375mm (0.015").

    The PathAssist LED Light Fiber is packaged alone or may be packaged with XprESS (LoProfile suction tip).

    AI/ML Overview

    This document describes the PathAssist LED Light Fiber, a device intended to locate, illuminate within, and transilluminate across nasal and sinus structures. The document is a 510(k) summary submitted to the FDA, indicating a claim of substantial equivalence to a predicate device, rather than a clinical study establishing new performance criteria. Therefore, the information provided focuses on demonstrating equivalence to an existing device rather than presenting detailed acceptance criteria and a study proving the device meets them in a conventional sense.

    Here's a breakdown based on the provided text, addressing the requested information to the extent possible:

    1. Table of Acceptance Criteria and Reported Device Performance

    Since this is a 510(k) submission for substantial equivalence, formal "acceptance criteria" for novel performance metrics are not explicitly stated in this document. Instead, the focus is on meeting "design specifications" and performing "as intended," which is implicitly tied to the performance of the predicate device.

    Performance CharacteristicAcceptance Criteria (Implicit from Predicate Equivalence)Reported Device Performance
    Light Emission DurationOver 60 minutes (based on predicate or new design spec)Emits red light from the distal tip for over 60 minutes
    Fiber Nominal Working Length27.6 cm (based on design specification)27.6 cm
    Outer Diameter0.375 mm (0.015") (based on design specification)0.375 mm (0.015")
    SterilitySterile and for single useProvided sterile and is for single use only
    Functional PerformancePerforms as intendedMeets design specifications and performed as intended
    Mechanical PerformancePerforms as intendedMeets design specifications and performed as intended
    CompatibilityPerforms as intendedMeets design specifications and performed as intended
    Thermal SafetySafeMeets design specifications and performed as intended
    BiocompatibilityBiocompatible (implicit from predicate)Not submitted, but claimed equivalent to predicate
    PackagingAdequate for sterility, shelf life (implicit from predicate)Not submitted, but claimed equivalent to predicate
    Shelf LifeAdequate for intended use (implicit from predicate)Not submitted, but claimed equivalent to predicate
    EMC and Electrical SafetyComplies with standards (implicit from predicate)Not submitted, but claimed equivalent to predicate

    2. Sample Size Used for the Test Set and Data Provenance

    The document states: "Performance testing of the PathAssist LED Light Fiber consisted of design verification testing to support the device modifications." It does not specify a "test set" in the context of clinical or large-scale comparative studies. The testing described is primarily benchtop design verification.

    • Sample Size: Not specified for individual tests.
    • Data Provenance: Not applicable in the context of clinical data. It's internal company design verification data. This is retrospective in the sense that it evaluates the modified device's adherence to design specifications.

    3. Number of Experts Used to Establish Ground Truth and Qualifications of Experts

    This information is not applicable as the document describes design verification testing, not a clinical study involving human readers or expert ground truth panels.

    4. Adjudication Method for the Test Set

    This information is not applicable as there is no "test set" in the context of expert review or clinical trial adjudication. Design verification results are typically evaluated against established engineering specifications.

    5. Multi-Reader Multi-Case (MRMC) Comparative Effectiveness Study

    A MRMC comparative effectiveness study was not done. The document explicitly states: "animal and clinical data were not submitted."

    6. Standalone Performance Study

    A standalone performance study (i.e., algorithm only without human-in-the-loop performance) was not done in the clinical sense. The "performance data" refers to "design verification testing" (functional, mechanical, compatibility, thermal safety), which assesses the device's physical and operational characteristics, not its clinical efficacy in a standalone context.

    7. Type of Ground Truth Used

    The "ground truth" for the design verification testing would be the engineering design specifications and established quality control parameters for the device's physical and functional attributes.

    8. Sample Size for the Training Set

    This information is not applicable. This device is a physical medical instrument, not an AI/ML algorithm that requires a training set.

    9. How the Ground Truth for the Training Set Was Established

    This information is not applicable for the same reason as point 8.

    Ask a Question

    Ask a specific question about this device

    Page 1 of 1